Germany Cardiac Biomarkers Market Size & Outlook, 2026-2033
The cardiac biomarkers market in Germany is expected to reach a projected revenue of US$ 2,762.8 million by 2033. A compound annual growth rate of 11.3% is expected of Germany cardiac biomarkers market from 2026 to 2033.
- Clinical Diagnostics
- Biomarkers
- cardiac biomarker market
- Biomarkers
Revenue, 2025 (US$M)
$1,185.8
Estimate, 2026 (US$M)
$1,309.7
Forecast, 2033 (US$M)
$2,762.8
CAGR, 2026 - 2033
11.3%
Global Market
Related Markets
GVR research-powered AI
Ask Prism AI about the cardiac biomarker market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Germany cardiac biomarkers market highlights
- The Germany cardiac biomarkers market generated a revenue of USD 1,185.8 million in 2025 and is expected to reach USD 2,762.8 million by 2033.
- The Germany market is expected to grow at a CAGR of 11.3% from 2026 to 2033.
- In terms of segment, troponin was the largest revenue generating type in 2025.
- Troponin is the most lucrative type segment registering the fastest growth during the forecast period.
Cardiac biomarkers market data book summary
| Market revenue in 2025 | USD 1,185.8 million |
| Market revenue in 2033 | USD 2,762.8 million |
| Growth rate | 11.3% (CAGR from 2026 to 2033) |
| Largest segment | Troponin |
| Fastest growing segment | Troponin |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK-MB, Myoglobin, Troponin, BNP and NT-proBNP |
| Key market players worldwide | Abbott Laboratories, QuidelOrtho Corp, Siemens Healthineers AG ADR, Roche Holding AG ADR, Danaher Corp, BioMerieux SA, Bio-Rad Laboratories Inc, Randox, Creative Diagnostics, Life Diagnostics |
Other key industry trends
- In terms of revenue, Germany accounted for 5.7% of the global cardiac biomarkers market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany cardiac biomarkers market is projected to lead the regional market in terms of revenue in 2033.
- UK is the fastest growing regional market in Europe and is projected to reach USD 2,205.5 million by 2033.
No credit card required*
Publish Date: Mar 16, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cardiac Biomarker Market
Cardiac biomarker market segmentation & scope
Cardiac Biomarker Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| QuidelOrtho Corp | View profile | 7,100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | www.quidelortho.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Creative Diagnostics | View profile | 51-100 | New York, New York, United States, North America | www.creative-diagnostics.com |
| Randox | View profile | 1001-5000 | Crumlin, Antrim, United Kingdom, Europe | www.randox.com |
| Life Diagnostics | View profile | 1-10 | West Chester, Pennsylvania, United States, North America | lifediagnostics.com |
Germany cardiac biomarker market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cardiac Biomarkers Market Outlook will help companies and investors design strategic landscapes.
Troponin was the largest segment with a revenue share of 40.11% in 2025.
Horizon Databook has segmented the Germany cardiac biomarkers market based on ck-mb, myoglobin, troponin, bnp and nt-probnp covering the revenue growth of each sub-segment from 2021 to 2033.
- Germany Cardiac Biomarkers Market Type Outlook (Revenue, USD Million , 2021-2033)
- Troponin
- CK-MB
- Myoglobin
- BNP and NT-proBNP
- Others
- Germany Cardiac Biomarkers Market Application Outlook (Revenue, USD Million , 2021-2033)
- Acute Coronary Syndrome
- Myocardial Infarction
- Congestive Heart Failure
- Others
- Germany Cardiac Biomarkers Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Laboratory Testing
- Point of Care Testing
Reasons to subscribe to cardiac biomarker market databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of cardiac biomarker market databook
- Our clientele includes a mix of cardiac biomarker market companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany cardiac biomarker market, including forecasts for subscribers. This country databook contains high-level insights into Germany cardiac biomarker market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Germany Cardiac Biomarkers Market, 2021-2033 (US$M)
Germany cardiac biomarker market statistics, by type, 2021-2033 (US$M)
